Irish biotechnology company Elan yesterday (Thursday) launched a $573.3m equity capital raising programme.
The money, which is being raised through an equity offering, is being lead managed by Morgan Stanley. It comprises the sale of 35m primary shares and a $400m convertible bond issue.Investor demand allowed the leads to ...
Please take a trial or subscribe to access this content.
Contact Mark Goodes to discuss your access: email@example.com